‹ ›
MYP_085452
Basic Information
Unnamed
Anticancer
Antimicrobial
Antimicrobial ▸ Antibacterial
Antiviral
Cardiovascular ▸ Blood pressure regulation ▸ Antihypertensive
Delivery / Targeting ▸ Targeting ligand ▸ Targeting
Enzyme modulation ▸ Enzyme inhibition
Enzyme modulation ▸ Enzyme inhibition ▸ ACE inhibition ▸ ACE inhibitory
Enzyme modulation ▸ Enzyme inhibition ▸ DPP-IV inhibition ▸ DPP-IV inhibitory
Metabolic ▸ Glucose metabolism ▸ Antidiabetic
Standard
2 amino acids
C12H26N6O3
Standard
Sequence
KR
Physicochemical Analysis
302.37 Da
11.00
1.76
1.55
0.8796
-4.20
1.35
-2.02
168.00
0.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
180.34
-1.72
7.0
5.0
11.0
21.0
0.0
1.0
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-19T04:49:33.503146+00:00. File readability does not guarantee 3D display.
Match index: Not listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0434487 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Escherichia coli ATCC 25922
128 μg/mL
MBFIC (resazurin metabolic endpoint; Etafilcon A hydrogel contact lens (CL); MHB II)
RECORD: Rec_0434488 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Proteus mirabilis PCM 543
512 μg/mL
MBFIC (resazurin metabolic endpoint; polystyrene (PS); MHB II)
RECORD: Rec_0434489 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Proteus mirabilis PCM 543
>512 μg/mL
MBFIC (resazurin metabolic endpoint; Etafilcon A hydrogel contact lens (CL); MHB II)
RECORD: Rec_0434490 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Staphylococcus aureus ATCC 25923
16 μg/mL
MBEC (resazurin metabolic endpoint; polystyrene (PS); MHB II)
RECORD: Rec_0434491 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Staphylococcus aureus ATCC 25923
512 μg/mL
MBEC (resazurin metabolic endpoint; Etafilcon A hydrogel contact lens (CL); MHB II)
FIRST PREV 1 ... 11 12 13 14 15 ... 20 NEXT LAST
Showing 5 records · Page 13 of 20